Related Experiment Video
Updated: Jan 23, 2026

Isolation of High-density Lipoproteins for Non-coding Small RNA Quantification
Published on: November 28, 2016
Evidence for changing lipid management strategy to focus on non-high density lipoprotein cholesterol
Xin Su1, Yi Kong2, Daoquan Peng3
1Department of Cardiovascular Medicine, the Second Xiangya Hospital of Central South University, No. 139 Middle Renmin Road, Changsha, 410011, Hunan, China.
Insights
Non-high-density lipoprotein cholesterol (non-HDL-C) better predicts cardiovascular risk than low-density lipoprotein cholesterol (LDL-C) in coronary heart disease patients. This review suggests focusing lipid management on non-HDL-C for improved outcomes.
Area of Science:
- Cardiology
- Lipid Metabolism
- Preventive Medicine
Background:
- Low-density lipoprotein cholesterol (LDL-C) has been the primary lipid target for coronary heart disease (CHD) for decades.
- Despite aggressive LDL-C lowering, a significant residual risk of major adverse cardiovascular events (MACE) persists.
- Non-high-density lipoprotein cholesterol (non-HDL-C) encompasses all atherogenic lipoproteins, including VLDL, LDL, and IDL.
Purpose of the Study:
- To review evidence supporting non-HDL-C as a superior predictor of MACE compared to LDL-C.
- To advocate for a shift in lipid management strategies towards non-HDL-C as a co-primary therapeutic target.
- To propose appropriate non-HDL-C goals in conjunction with LDL-C targets for cardiovascular prevention.
Main Methods:
- Systematic review of prospective observational studies on lipid levels and MACE risk.
- Analysis of current guideline recommendations regarding LDL-C and non-HDL-C targets.
- Evaluation of the clinical utility of non-HDL-C for risk stratification and treatment guidance.
Main Results:
- Numerous studies demonstrate non-HDL-C's superior predictive value for MACE over LDL-C.
- Current guidelines increasingly emphasize non-HDL-C for cardiovascular risk assessment and management.
- Existing recommendations for non-HDL-C goals (30 mg/dL higher than LDL-C) may be suboptimal.
Conclusions:
- Non-HDL-C offers a more comprehensive assessment of atherogenic lipoprotein burden and cardiovascular risk.
- Shifting the primary focus to non-HDL-C in lipid management strategies is warranted.
- Revised, evidence-based non-HDL-C targets are needed to optimize cardiovascular event prevention in CHD patients.
Abstract:
Low-density lipoprotein cholesterol (LDL-C) has been recommended as the primary treatment target on lipid management in coronary heart disease (CHD) patients for past several decades. However, even by aggressive LDL-C lowering treatment, patients still present a significant residual risk of major adverse cardiovascular events (MACE). Non-high-density lipoprotein cholesterol (non-HDL-C) contained all the atherogenic lipoproteins, such as chylomicron, very-low density lipoprotein (VLDL), LDL, intermediate density lipoprotein (IDL). Many prospective observation studies have found that non-HDL-C was better than LDL-C in predicting risks of MACE. Since non-HDL-C appears to be superior for risk prediction beyond LDL-C, current guidelines have emphasize the importance of non-HDL-C for guiding cardiovascular prevention strategies and have flagged non-HDL-C as a co-primary therapeutic target. The goals of non-HDL-C were recommended as 30 mg/dl higher than the corresponding LDL-C goals, but the value seemed inappropriate. This review provide evidence for changing lipid management strategy to focus on non-HDL-C and appropriate values for adding to LDL-C goals would be proposed.
More Related Videos
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Related Concept Videos
Coping Strategies: Problem Focused
For example, consider a student who struggles to understand their...
Coping Strategies: Emotion Focused
The Evidence for Evolution
What are Lipids?
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid Digestion